Ewing sarcoma in adults treated with modern radiotherapy techniques Journal Article


Authors: Casey, D. L.; Meyers, P. A.; Alektiar, K. M.; Magnan, H.; Healey, J. H.; Boland, P. J.; Wolden, S. L.
Article Title: Ewing sarcoma in adults treated with modern radiotherapy techniques
Abstract: Background and purpose To evaluate local control and survival outcomes in adults with Ewing sarcoma (ES) treated with radiotherapy (RT). Material and methods Retrospective review of all 109 patients age ≥18 treated for ES with RT to the primary site at Memorial Sloan Kettering Cancer Center between 1990 and 2011. RT was used as the definitive local control modality in 44% of patients, preoperatively for 6%, and postoperatively for 50%. Results Median age at diagnosis was 27 years (range, 18-67). The 5-year local failure (LF) was 18%. Differences in LF were not identified when evaluated by modality of local control (RT versus combined surgery and RT), RT dose, fractionation, and RT technique. However, margin status at time of resection significantly predicted LF. The 5-year event-free survival and overall survival rates were 44% and 66% for patients with localized disease, compared with 16% and 26% for metastatic disease (p = 0.0005 and 0.0002). Tumor size, histopathologic response to chemotherapy, and treatment on or according to a protocol were also significantly associated with survival. Conclusions This series of adults treated with modern chemotherapy and RT had prognostic factors and outcomes similar to adolescents with ES. All adults with ES should be treated with an aggressive, multidisciplinary approach.
Keywords: adult; cancer chemotherapy; cancer survival; event free survival; treatment outcome; treatment response; aged; major clinical study; overall survival; doxorubicin; cancer radiotherapy; temozolomide; tumor volume; etoposide; cyclophosphamide; vincristine; clinical protocol; ifosfamide; irinotecan; ewing sarcoma; radiation dose fractionation; radiation therapy; local control; cancer control; adults; local failure free survival; human; male; female; article
Journal Title: Radiotherapy and Oncology
Volume: 113
Issue: 2
ISSN: 0167-8140
Publisher: Elsevier Inc.  
Date Published: 2014-11-01
Start Page: 248
End Page: 253
Language: English
DOI: 10.1016/j.radonc.2014.11.023
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 2 January 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Patrick J Boland
    160 Boland
  2. Kaled M Alektiar
    333 Alektiar
  3. Suzanne L Wolden
    560 Wolden
  4. Paul Meyers
    311 Meyers
  5. John H Healey
    547 Healey
  6. Heather Magnan
    31 Magnan
  7. Dana   Casey
    55 Casey